New vaccine blocks COVID-19 and varia... - Lung Conditions C...

Lung Conditions Community Forum

56,005 members66,633 posts

New vaccine blocks COVID-19 and variants, plus other coronaviruses

2greys profile image
3 Replies

A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections -- including SARS-CoV-2 as well as the original SARS-CoV-1 and related bat coronaviruses that could potentially cause the next pandemic.

The new vaccine, called a pan-coronavirus vaccine, triggers neutralizing antibodies via a nanoparticle. The nanoparticle is composed of the coronavirus part that allows it to bind to the body’s cell receptors, and is formulated with a chemical booster called an adjuvant. Success in primates is highly relevant to humans.

corporate.dukehealth.org/ne...

Written by
2greys profile image
2greys
To view profiles and participate in discussions please or .
Read more about...
3 Replies
Suzie42 profile image
Suzie42

Sounds promising 🤞

Jaybird19 profile image
Jaybird19

think we should get an order in ? indian variant is here and doubling cases in some places.

Dedalus profile image
Dedalus

More good news - we need all the help we can get.

Not what you're looking for?

You may also like...

Investigational COVID-19 vaccine well-tolerated and generates immune response in older adults.

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that...

‘Universal Covid vaccine’ could be developed within a year, Second-generation jab may work against all variants of coronavirus.

Scancell Holdings plc, (AIM:SCLP), the developer of novel immunotherapies is pleased to announce...

Test confirms no trace of coronavirus in Canberra's sewage.

A comprehensive testing program has found no traces of SARS-CoV-2 in Canberra's sewage system. The...

Do we need a COVID-19 vaccine for pets?

SARS-CoV-2 has never been an exclusively human problem. Since the early days of the pandemic,...

Phase 2/3 trial of Oxford COVID-19 vaccine in healthy older adults finds it is safe and provokes immune response.

The UK's vaccine against SARS-CoV-2 shows similar safety and immunogenicity results in healthy...